Listing & Compliance Notices

Boxlight Corp received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(b)(1)(A)).

“ting Rule or Requirement; Transfer of Listing. As previously reported in the Company’s Current Report on Form 8-K filed on June 4, 2025, R. Wayne Jackson resigned as a director of the Company on May 23, 2025. Mr. Jackson’s resignation resulted in the Company not being in compliance with Nasdaq Rule 5605(b)(1), which requires that a majority of the Board must be comprised of independent directors as defined in Nasdaq listing standards. Pursuant to Nasdaq Rule 5605(b)(1)(A), the Company has 180 days from the date of Mr. Jackson’s resignation, or until November 19, 2025, to cure this noncomplianc”

Oak Woods Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“August 8, 2025, Oak Woods Acquisition Corporation (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the Company no longer meets the minimum 300 public holders requirement for The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(3) (the “ Minimum Public Holders Requirement ”). In accordance with Nasdaq rules, the Company has 45 calendar days, or until September 22, 2025, to submit a plan to regain compliance with the Minimum Public Holders Requirement. If the plan is”

URBAN ONE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 11, 2025, the Company received written notice (the “Notice”) from the Listing Qualifications Department of NASDAQ notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Class D common stock, par value $0.001 per share (the “Class D Common Stock”) had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the NASDAQ Capital Market pursuant to NASDAQ Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice had and has no immediate effect on the listing of the Class D Common Stock, which c”

Ontrak, Inc. received a nasdaq deficiency notice notice regarding other (rules 5101).

“August 7, 2025, Ontrak, Inc. (the “Company”), received a letter from The Nasdaq Stock Market, LLC (“Nasdaq”) stating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) because the closing bid price for the Company’s common stock was less than $1.00 from June 25 through August 6, 2025. As previously reported, the Company is subject to a Nasdaq Discretionary Panel Monitor for a one-year period from October 7, 2024. As such, the Company is not eligible for a grace period within which to regain compliance wi”

Ontrak, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 7, 2025, Ontrak, Inc. (the “Company”), received a letter from The Nasdaq Stock Market, LLC (“Nasdaq”) stating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) because the closing bid price for the Company’s common stock was less than $1.00 from June 25 through August 6, 2025. As previously reported, the Company is subject to a Nasdaq Discretionary Panel Monitor for a one-year period from October 7, 2024. As such, the Company is not eligible for a grace period within which to regain compliance wi”

Sotherly Hotels Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“August 12, 2025, Sotherly Hotels Inc., a Maryland corporation (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it had been granted an additional 180 days, or until February 9, 2026 (the “Second Compliance Period”), to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), based on the”

Ovid Therapeutics Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“August 12, 2025, that the Company’s application to transfer to the Nasdaq Capital Market was approved and the Company is eligible for an additional 180 calendar day period, or until February 9, 2026 (the “Second Compliance Date”), to regain compliance with the minimum bid price requirement. At the opening of business on August 14, 2025, the Company’s common stock will be transferred to the Nasdaq Capital Market, which operates in substantially the same manner as the Nasdaq Global Select Market, where it continues to trade under the symbol “OVID.” The Company intends to monitor the closing bid”

bioAffinity Technologies, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“ies will be scheduled for delisting from The Nasdaq Capital Market and will be suspended at the opening of business on August 18, 2025. In addition, as of the date hereof, the Company has not regained compliance with the Continued Listing Equity Requirement. As a result and pursuant to Listing Rule 5810(d)(2), this deficiency now serves as an additional basis for delisting of the Company’s securities. The Company intends to submit an appeal to Nasdaq on August 14, 2025, which will stay the delisting and suspension of the Company’s securities pending the decision of the Panel. Hearings are typi”

bioAffinity Technologies, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“ies will be scheduled for delisting from The Nasdaq Capital Market and will be suspended at the opening of business on August 18, 2025. In addition, as of the date hereof, the Company has not regained compliance with the Continued Listing Equity Requirement. As a result and pursuant to Listing Rule 5810(d)(2), this deficiency now serves as an additional basis for delisting of the Company’s securities. The Company intends to submit an appeal to Nasdaq on August 14, 2025, which will stay the delisting and suspension of the Company’s securities pending the decision of the Panel. Hearings are typi”

Big Digital Energy, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 6, 2025, the Company received written notice from the Staff notifying the Company that it had not regained compliance with the Bid Price Rule by the Compliance Date (the “Bid Price Deficiency”) and that the Nasdaq Hearings Panel (the “Panel”) will consider the Bid Price Deficiency in rendering a determination regarding the Company’s continued listing on The Nasdaq Capital Market. At its hearing before the Panel, the Company will request an extension to regain compliance with the Bid Price Rule. There can be no assurance that the Company will be able to regain compliance with the Bid Pri”

ECD Automotive Design, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5810(c)(3)(A)(ii)).

“August 6, 2025, the Company received another notice (the “Additional Notice”) from Nasdaq stating that the Company had not regained compliance with the Rule. Accordingly, unless the Company requests an appeal of the determination before the Nasdaq Hearings Panel (the “Panel”) by August 13, 2025, trading of the Company’s common stock and warrants will be suspended at the opening of business on August 15, 2025, and a Form 25-NSE will be filed with the Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company intends to timely request an appeal be”

ECD Automotive Design, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5560(a)).

“August 6, 2025, the Company received another notice (the “Additional Notice”) from Nasdaq stating that the Company had not regained compliance with the Rule. Accordingly, unless the Company requests an appeal of the determination before the Nasdaq Hearings Panel (the “Panel”) by August 13, 2025, trading of the Company’s common stock and warrants will be suspended at the opening of business on August 15, 2025, and a Form 25-NSE will be filed with the Commission, which will remove the Company’s securities from listing and registration on Nasdaq. The Company intends to timely request an appeal be”

VSEE HEALTH, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“December 31, 2024 (the “Form 10-K”) with the Securities and Exchange Commission (the “SEC”). As previously reported, on May 23, 2025, the Company received a notice (the “Second Notice” and, together with the First Notice, the “Notices”) from the Staff of Nasdaq that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Form 10-Q”) with the SEC. On August 5, 2025, the Company received a letter from the Staff stating that the Staff had determined to deny the Compan”

ClearSign Technologies Corp received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(c)(2)(A)).

“August 8, 2025, ClearSign Technologies Corporation (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with the board of directors independence requirement set forth in Nasdaq Listing Rule 5605(b)(1) and the audit committee composition requirement set forth in Nasdaq Listing Rule 5605(c)(2)(A) (collectively, the “Nasdaq Composition Requirements”) due to the resignations of Catharine M. de Lacy and Judith S. Schrecker (as described below) from the Company’s board of di”

Processa Pharmaceuticals, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“August 7, 2025, the Company received a letter from the Staff notifying that the Company is eligible for a second 180-day period, or until February 2, 2026 (the “Second Grace Period”) to regain compliance with the Bid Price Requirement. According to the notification from Nasdaq, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, with the exception of the minimum bid price requirement, and (ii) the Company’s written notice to Nasdaq of its intention to cure t”

Barnes & Noble Education, Inc. received a nyse deficiency notice notice regarding late filing (rules 802.01E).

“August 4, 2025, Barnes & Noble Education, Inc. (the “Company”) received a notice of noncompliance (the “NYSE Notice”) from the New York Stock Exchange (“NYSE”) noting that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to the delayed filing of the Company’s Annual Report on Form 10-K for the fiscal year ended May 3, 2025 (the “Form 10-K”). As previously reported in the Company’s Notification of Late Filing on Form 12b-25 filed with the SEC on July 18, 2025, the Company was unable to file the Form 10-K within the prescribed period without unreasonabl”

Zoomcar Holdings, Inc. received a otc deficiency notice notice regarding market value.

“August 5, 2025, Zoomcar Holdings, Inc. (the “Company”) received a written notice from the OTCQX U.S. tier of OTC Markets Group (“OTCQX”) stating that the Company’s Global Market Capitalization has remained below the minimum $5 million required under Section 2.1(B) of the OTCQX Rules for U.S. Companies for more than 30 consecutive calendar days and, therefore, the Company no longer satisfies the OTCQX Standards for Continued Qualification. Under those rules, the Company has a 90-calendar-day cure period, expiring on November 3, 2025, to regain compliance by maintaining a Global Market Capitaliz”

FibroBiologics, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“August 4, 2025, FibroBiologics, Inc. (the “Company”) received a notification letter from the Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it does not meet the requirement in Nasdaq Listing Rule 5550(b)(2) to maintain a minimum Market Value of Listed Securities (“MVLS”) of $35.0 million that is required for continued listing on The Nasdaq Capital Market (the “Notice”). The Notice has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market subject”

Twin Hospitality Group Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(3)(C)).

“August 4, 2025, Twin Hospitality Group Inc. (the “Company”) received a written notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) that, for the 30 consecutive business days ended July 28, 2025, the Company’s Market Value of Publicly Held Shares (“MVPHS”) closed below the $15,000,000 MVPHS threshold required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rules 5450(b)(2)C) and 5450(b)(3)C) (the “MVPHS Rule”). Nasdaq stated in its letter that in accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company has a compliance period of 18”

Estrella Immunopharma, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“August 1, 2025, Estrella Immunopharma, Inc. (the “ Company ”) received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires listed securities to maintain a minimum Market Value of Listed Securities (“ MVLS ”) of $35,000,000. The Company has not met this requirement for the 30 consecutive business days preceding the date of the notice. The notice indicated the period of non-compliance was from June 13, 2025, to July 31, 2025. The notice also not”

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).

“July 7, 2025, Renovaro Inc. (the “Company”) received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a), which requires listed companies to hold an annual meeting of shareholders within twelve months of the end of their fiscal year. On August 5, 2025, the Company received written confirmation from Nasdaq that it has accepted the Company’s plan to regain compliance and has granted an extension until October 31, 2025, for the Company to hold its annual meeting of shareholders. The Company intends to hold the ann”

VINCE HOLDING CORP. received a nyse extension granted notice regarding other (rules 802.01B).

“August 5, 2025, Vince Holding Corp. (the "Company") received notification (the "Acceptance Letter") from The New York Stock Exchange (the "NYSE") that it has accepted the Company's previously-submitted plan (the "Plan") to regain compliance with the NYSE's continued listing standard under Section 802.01B of the NYSE Listed Company Manual (the "Manual"), which requires the Company's 30-trading day average market capitalization to be not less than $50 million and the Company's stockholders' equity to be not less than $50 million ("Section 802.01B"). As previously disclosed, on May 6, 2025 the Co”

SeaStar Medical Holding Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“Company that, for the preceding 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”) was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The notification received has no immediate effect on the Company’s Nasdaq listing. In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or until January 27, 2026 (the “Compliance Date”), to regain compliance”

SeaStar Medical Holding Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 31, 2025, SeaStar Medical Holding Corporation (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”) was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The notification received has no immediate effect on”

Ocean Biomedical, Inc. received a nasdaq delisting notice notice regarding other (rules 5820(e)(6), 5830).

“July 31, 2025, the Company was notified by Nasdaq that The Nasdaq Stock Market LLC Board of Directors has declined to call for review the May 15, 2025 decision of the Nasdaq Listing and Hearing Review Council (the “Listing Council”) in the Company’s appeal proceding. Accordingly, pursuant to Nasdaq Rule 5820(e)(6), the decision of the Listing Council represents Nasdaq’s final action in this matter. Nasdaq will follow the procedures contained in Nasdaq Rule 5830 and the Securities and Exchange Commission (“SEC”) Rule 12d2-2 to remove the Company’s securities from listing.”

Flux Power Holdings, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“July 31, 2025, the Company received a determination letter from the Staff notifying the Company that based on the Company’s most recent disclosure, the Company’s stockholders’ equity was ($4,372,000) as of March 31, 2025 and that the Staff had determined that the Company had not regained compliance with the Stockholders’ Equity Requirement. The Staff has informed the company that trading of the Company’s common stock will be suspended at the opening of business on August 11, 2025, unless the Company requests an appeal of the Staff’s determination to a Nasdaq Hearings Panel (the “Panel”). The C”

iBio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 29, 2025, iBio, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (June 13, 2025 to July 28, 2025), the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”), as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on The Nasdaq Capital Market”

Senmiao Technology Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“July 29, 2025, Senmiao Technology Limited (the “Company”) received a deficiency notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that its common stock, par value $0.0001 per share (the “Common Stock”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital Market. Pursuan”

DIH HOLDING US, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“July 29, 2025, DIH Holding US, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the period ended March 31, 2025 (the “Form 10K”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. Under Na”

ScanTech AI Systems Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(C)).

“July 30, 2025, ScanTech AI Systems Inc. (the “Company”) received a deficiency letter (the “MVPHS Notice”) from Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon Nasdaq’s review of the Company’s market value of publicly held shares (“MVPHS”) for previous 30 consecutive business days ended July 28, 2025, the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(C) to maintain a MVPHS of at least $15 million (the “MVPHS Requirement”). In accordance with Nasdaq rules, the Company has a period of 180 calendar days (o”

Lakeside Holding Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

“July 28, 2025, Lakeside Holding Limited (the “Company”) received a letter (the “Notice”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, the Company had failed to comply with the minimum bid price of $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”), based on the closing bid price of the Company’s common stock for the previous 30 consecutive business days from June 12 to July 28, 2025 1 . In accordance with N”

AMERICAS CARMART INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“July 31, 2025, America’s Car-Mart, Inc. (the “Company”) received an expected notice (the “Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2025 (the “Annual Report”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires timely filing of all required periodic financial reports with the SEC. As previously disclosed in”

GeoVax Labs, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 31, 2025, the “Company received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company’s common stock was below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or until January 27, 2026 (the “Compliance Date”), to”

SHINECO, INC. received a nasdaq hearing update notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“July 28, 2025, the Company received notice that the Nasdaq Listing and Hearing Review Council (the “Listing Council”), pursuant to its authority under Nasdaq Listing Rule 5820(b), decided to call this matter for review and to grant a stay of the Panel Decision pending the outcome of that review, thereby staying the suspension of trading and delisting of the Company’s common stock pending further review by the Listing Council (the “Listing Council Letter”). Specifically, the Listing Council Letter confirmed that the Listing Council stayed the effectiveness of the July 25, 2025, Panel Decision p”

Big Digital Energy, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“January 24, 2025, Mawson Infrastructure Group Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the 33 consecutive business days preceding the date of the Notice, the Company’s Market Value of Listed Securities (“MVLS”) was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Staff provided the Company”

Big Digital Energy, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“July 24, 2025, the Company received written notice (the “Delisting Notice”) from the Staff indicating that based upon the Company’s continued non-compliance with the MVLS Rule on the Compliance Date, the Company’s securities were subject to delisting unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which request will stay any further suspension or delisting action by the Staff at least pending the hearing before the Panel. At the hearing, the Company will request an extension to regain c”

SPLASH BEVERAGE GROUP, INC. received a nyse_american delisting notice notice regarding other (rules 1001).

“July 23, 2025, Splash Beverage Group, Inc. (the “Company”) received notice from NYSE Regulation that it has determined to commence delisting proceedings with respect to the Company’s publicly traded warrants to purchase shares of common stock for $1.84 per share, which are listed on NYSE American under the symbol SBEV-WT (the “Public Warrants”). The notice stated that the Public Warrants are no longer suitable for continued listing pursuant to Section 1001 of the NYSE American Company Guide due to their low trading price. As a result, trading in the Public Warrants was suspended effective imme”

Phunware, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(2)(A), 5605(a)(2), 10A-3).

“July 24, 2025, Phunware, Inc. (the "Company") notified The Nasdaq Stock Market LLC ("Nasdaq") that, as a result of the resignation of Rahul Mewawalla from the Company’s audit committee in connection with his appointment as Executive Chair and Chief Artificial Intelligence Architect as described below, the Company is not in compliance with Nasdaq’s audit committee composition requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to Nasdaq Listing Rule 5605(c)(2)(A), a listed company must have an audit committee of at least three members, each of whom must be an Independent Director as”

AIxCrypto Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“July 24, 2025, the Company received a follow-up communication from the Office of the General Counsel of Nasdaq confirming that Nasdaq had granted the Company’s request for an extension to regain compliance. Nasdaq acknowledged that: The Company timely filed its Quarterly Report on Form 10-Q on or before the required deadline of July 21, 2025; The Company has demonstrated compliance with the Equity Rule on a pro forma basis following the closing of a $4.5 million private placement of Series A-3 Preferred Stock, before customary fees and expenses; and The Company submitted a compliance plan outl”

Nuburu, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i)).

“April 29, 2025, received a Notice of Noncompliance (the “Notice”) from NYSE Regulation indicating that the Company was not in compliance with Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) since it reported stockholders’ deficit of $(37.8) million at December 31, 2024 and has had losses in the two most recent fiscal years. The NYSE will review the Company periodically for compliance with the Compliance Plan. If the Company is not in compliance with the continued listing standards by October 29, 2026, or if the Company does not make progress consistent with the Comp”

Wag! Group Co. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1, 5450(a)(1), 5450(b)(2)(A), 5450(b)(2)(C)).

“July 23, 2025, the Company received written notice (the “ Delisting Notice ”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq determined that the Company’s common stock and warrants will be delisted from the Nasdaq Capital Market. Accordingly, Nasdaq indicated that trading of the Company’s common stock will be suspended from the Nasdaq Capital Market at the opening of business on July 30, 2025, and a Form 25-NSE will be filed with the Securities and Exch”

GRAPHJET TECHNOLOGY received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5450(c)(1)).

“July 25, 2025, Graphjet Technology (the “Company” or “Graphjet”) received a decision letter (the “Letter”) from the Nasdaq Hearings Panel (the “Panel”) granting the Company’s request to continue its listing on The Nasdaq Stock Market (“Nasdaq”). The decision is conditioned on the Company (i) demonstrating compliance with Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Rule”) on or before August 29, 2025, (ii) demonstrating compliance with Nasdaq Listing Rule 5450(c)(1) (the “Periodic Filing Rule” and, together with the Bid Price Rule, the “Listing Rules”) on or before September 15, 2025, and (i”

GENCOR INDUSTRIES INC received a nyse_american compliance regained notice regarding late filing (rules 1007).

“July 25, 2025, which was prior to the New Cure Deadline. On July 25, 2025, the Company received a notification letter from the NYSE indicating that the Company has now regained compliance with Section 1007 of the NYSE American Company Guide and will be removed from the NYSE’s late filers’ list. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENCOR INDUSTRIES, INC. July 28, 2025 By: /s/ Marc G. Elliott Marc G. Elliott, President July 28, 2025 By: /s”

STAR EQUITY HOLDINGS, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(1)(c), 5810(c)(3)(D)).

“July 24, 2025, Star Equity Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Market Value of Publicly Held Shares (“MVPHS”) was below the minimum MVPHS of $5,000,000 required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(1)(c). In accordance with Nasdaq Listing Rule 5810(c)(3)(D), and as indicated in the Letter, the Company has 180 calendar days, or until January 20, 2026, to regain compliance with the minimum MVPHS requiremen”

AXT INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

“July 18, 2025. Other than the correction of the date, no other changes have been made to the Initial Report. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . (a) As previously, on July 14, 2025, AXT, Inc. (the “Company”) notified The Nasdaq Stock Market (“Nasdaq”) that as a result of the recent passing of Ms. Christine Russell, the Company is not compliant with Nasdaq Lising Rule 5605(c)(2)(A) as the Company’s Audit Committee currently consists of only two independent directors, rather than the minimum three independent directors a”

Advanced Biomed Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“July 18, 2025, Advanced Biomed Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 32 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing or trading of the Company’s common stock, which will continue to trade o”

AXT INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

“January 18, 2025, Nasdaq notified the Company that due to the passing of Ms. Russell, the Company no longer complies with the audit committee requirement under Nasdaq Lising Rule 5605(c)(2)(A). Nasdaq further notified the Company that, consistent with Nasdaq Listing Rule 5605(c)(4), Nasdaq will provide the Company a cure period in order to regain compliance (i) until the earlier of the Company’s next annual meeting of shareholders or July 11, 2026; or, (ii) if the next annual meeting of shareholders is held before January 7, 2026, then the Company must provide evidence of compliance no later t”

DYADIC INTERNATIONAL INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

“July 17, 2025, Dyadic International, Inc. (the “Company”) received a deficiency notice (the “Notice”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the Company’s securities have not maintained the minimum bid price of at least $1 per share required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rule 5810(”

TECHPRECISION CORP received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“July 18, 2025, TechPrecision Corporation (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because it had not timely filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “ Form 10-K ”) with the Securities and Exchange Commission (the “ SEC ”) on or before July 15, 2025, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amen”

NIOCORP DEVELOPMENTS LTD received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).

“July 22, 2025, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) that due to Mr. Morris’ death, the Company’s Audit Committee has been reduced to two independent directors, and the Company is not compliant with Nasdaq Listing Rule 5605(c)(2)(A), which requires the Audit Committee to be comprised of a minimum of three independent directors. Pursuant to Nasdaq Listing Rule 5605(c)(4)(B), the Company has a cure period to regain compliance until the earlier of the Company’s next annual meeting of shareholders and July 20, 2026; provided that if the Company holds its next annual meeting o”